AAM welcomes Biden’s nomination of Robert Califf to lead FDA
The organization said it is ready to work with Robert Califf to ensure America’s patients have access to generic and biosimilar medicines.
The Association for Accessible Medicines supports President Biden’s nomination of Dr. Robert Califf to serve as commissioner of the Food and Drug Administration.
[Read more: President Biden to nominate Robert Califf as FDA commissioner]
In the wake of this news, the organization shared a statement highlighting their thoughts on the nomination.
“If Dr. Califf is confirmed, AAM and its member companies stand ready to work with Dr. Califf and the entire FDA team to ensure America’s patients have timely access to safe, effective and quality generic and biosimilar medicines,” the organization said.